Literature DB >> 12120906

Hearing loss and middle ear involvement in rheumatoid arthritis.

Müge Ozcan1, M Fatih Karakuş, Osman Hakan Gündüz, Umit Tuncel, Hasan Sahin.   

Abstract

In this controlled study, hearing and middle ear functions were investigated in 37 patients with rheumatoid arthritis (RA) and 35 controls in order to study the prevalence and the nature of hearing loss in RA. The prevalence of the hearing impairment was significantly higher in the RA group, and the majority was bilateral (P<0.001). Of the patients, 35.1% had sensorineural (SN), 24.3% had conductive loss, and 10.8% had a mixed type of hearing loss. The hearing loss was positively correlated to the Steinbrocker functional index. The prevalence of abnormal tympanograms was 37.8%, while it was 17.1% in the control group. The probable site of involvement responsible for the SN loss was the cochlea, and discontinuity of the ossicles, rather than stiffness, was responsible for the conductive hearing loss. The presence of a mixed type of hearing loss suggested a multifocal involvement of the audiologic system in RA.

Entities:  

Mesh:

Year:  2002        PMID: 12120906     DOI: 10.1007/s00296-002-0185-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  23 in total

1.  Auditory brainstem response (ABR) abnormalities across the life span of rats prenatally exposed to alcohol.

Authors:  Michael W Church; John W Hotra; Pamela A Holmes; Jennifer I Anumba; Desmond A Jackson; Brittany R Adams
Journal:  Alcohol Clin Exp Res       Date:  2011-08-04       Impact factor: 3.455

2.  Sensorineural hearing loss in patients with inflammatory bowel disease: a subclinical extraintestinal manifestation.

Authors:  Nihat Akbayir; Asli Batur Caliş; Canan Alkim; H Mehmet Mehmet Sökmen; Levent Erdem; Ayça Ozbal; Füsun Bölükbaş; Nihat Akbayir
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

3.  The expression of tenascin-C and tenascin-W in human ossicles.

Authors:  Richard P Tucker; Cathryn A Peterson; Ismail Hendaoui; Sandrine Bichet; Ruth Chiquet-Ehrismann
Journal:  J Anat       Date:  2016-05-27       Impact factor: 2.610

4.  Cumulative disease activity predicts incidental hearing impairment in patients with rheumatoid arthritis (RA).

Authors:  Virginia Pascual-Ramos; Irazú Contreras-Yáñez; Paula Rivera-Hoyos; Lorena Enríquez; Jaqueline Ramírez-Anguiano
Journal:  Clin Rheumatol       Date:  2014-01-18       Impact factor: 2.980

5.  Relationship between disease activity and hearing impairment in patients with rheumatoid arthritis compared with controls.

Authors:  Adem Yildirim; Gulseren Surucu; Sedat Dogan; Mehmet Karabiber
Journal:  Clin Rheumatol       Date:  2015-11-28       Impact factor: 2.980

6.  Supervised machine learning and logistic regression identifies novel epistatic risk factors with PTPN22 for rheumatoid arthritis.

Authors:  F B S Briggs; P P Ramsay; E Madden; J M Norris; V M Holers; T R Mikuls; T Sokka; M F Seldin; P K Gregersen; L A Criswell; L F Barcellos
Journal:  Genes Immun       Date:  2010-01-21       Impact factor: 2.676

Review 7.  Association of rheumatoid arthritis with hearing loss: a systematic review and meta-analysis.

Authors:  Nikolaos Chaitidis; Patroklos Theocharis; Charalampos Festas; Ioanna Aritzi
Journal:  Rheumatol Int       Date:  2020-06-02       Impact factor: 2.631

8.  Subjective audiological tests and transient evoked otoacoustic emissions in patients with rheumatoid arthritis: analysis of the factors affecting hearing levels.

Authors:  Oğuzhan Dikici; Nuray Bayar Muluk; Aliye Kapukiran Tosun; Ihsan Unlüsoy
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-04-10       Impact factor: 2.503

9.  Does rheumatoid arthritis have an effect on audiovestibular tests?

Authors:  Mahmut Özkırış; Zeliha Kapusuz; İlhan Günaydın; Utku Kubilay; İlyas Pırtı; Levent Saydam
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-12       Impact factor: 2.503

10.  Hearing impairment in patients with rheumatoid arthritis: association with anti-citrullinated protein antibodies.

Authors:  Fabrício Silva Lobo; Mario Orlando Dossi; Lígia Batista; Márcia Midori Shinzato
Journal:  Clin Rheumatol       Date:  2016-04-26       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.